Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
LDI
|
Anthony Li Hsieh
Director |
SELL
Open market or private sale
|
Indirect | 276,913 Reduced 0.0% |
$678,436
$2.45 p/Share
|
Sep 10
2024 |
OPRT
|
Jonathan Aaron Coblentz
CFO & Chief Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,706 Reduced 1.57% |
-
|
Sep 10
2024 |
EOSE
|
Cerberus Capital Management Ii, L.P. |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 7 Reduced 0.0% |
-
|
Sep 10
2024 |
EOSE
|
Cerberus Capital Management Ii, L.P. |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 59 Reduced 0.0% |
-
|
Sep 10
2024 |
PRDO
|
Michele A Peppers
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 6,476 Reduced 9.46% |
$135,996
$21.0 p/Share
|
Sep 10
2024 |
PRVA
|
Parth Mehrotra
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 135,142 Reduced 35.29% |
$2,500,127
$18.5 p/Share
|
Sep 10
2024 |
PRVA
|
Parth Mehrotra
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 135,142 Added 26.09% |
$270,284
$2.0 p/Share
|
Sep 10
2024 |
YOU
|
Kenneth L. Cornick
President & CFO |
SELL
Open market or private sale
|
Indirect | 400 Reduced 0.0% |
$12,400
$31.0 p/Share
|
Sep 10
2024 |
IT
|
James C Smith
Director |
SELL
Open market or private sale
|
Direct | 2,128 Reduced 0.37% |
$1,064,319
$500.15 p/Share
|
Sep 10
2024 |
BIRD
|
Ravi Thanawala
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8,334 Added 50.0% |
-
|
Sep 10
2024 |
CDW
|
David W Nelms
Director |
BUY
Grant, award, or other acquisition
|
Direct | 81 Added 0.28% |
-
|
Sep 10
2024 |
HCA
|
Michael S. Cuffe
EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 13,722 Reduced 26.51% |
$5,302,592
$386.43 p/Share
|
Sep 10
2024 |
HCA
|
Michael S. Cuffe
EVP and Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 22,080 Added 29.9% |
$3,206,899
$145.24 p/Share
|
Sep 10
2024 |
CDW
|
Sona Chawla
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7 Added 0.03% |
-
|
Sep 10
2024 |
CDW
|
Christine A Leahy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 21 Added 0.02% |
-
|
Sep 10
2024 |
CDW
|
Lynda M Clarizio
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2 Added 0.01% |
-
|
Sep 10
2024 |
CDW
|
Christina M Corley
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7 Added 0.01% |
-
|
Sep 10
2024 |
CDW
|
Virginia C. Addicott
Director |
BUY
Grant, award, or other acquisition
|
Direct | 44 Added 0.28% |
-
|
Sep 10
2024 |
CDW
|
Sanjay Mehrotra
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5 Added 0.14% |
-
|
Sep 10
2024 |
CDW
|
James A Bell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 53 Added 0.24% |
-
|
Sep 10
2024 |
CDW
|
Anthony R Foxx
Director |
BUY
Grant, award, or other acquisition
|
Direct | 11 Added 0.28% |
-
|
Sep 10
2024 |
CDW
|
Albert Joseph Miralles Jr
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7 Added 0.04% |
-
|
Sep 10
2024 |
CDW
|
Donna F Zarcone
Director |
BUY
Grant, award, or other acquisition
|
Direct | 38 Added 0.19% |
-
|
Sep 10
2024 |
CDW
|
Joseph Swedish
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7 Added 0.04% |
-
|
Sep 10
2024 |
CDW
|
Frederick J. Kulevich
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4 Added 0.02% |
-
|
Sep 10
2024 |
CDW
|
Marc Ellis Jones
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4 Added 0.23% |
-
|
Sep 10
2024 |
CDW
|
Kelly J Grier
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2 Added 0.15% |
-
|
Sep 10
2024 |
CDW
|
Peter R Locy
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1 Added 0.06% |
-
|
Sep 10
2024 |
CMI
|
Ashwath Ram
V.P. - Supply Chain |
BUY
Discretionary transaction
|
Indirect | 77 Added 0.0% |
$22,731
$295.22 p/Share
|
Sep 10
2024 |
SKIL
|
Richard Walker
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 90 Reduced 0.36% |
$1,128
$12.54 p/Share
|
Sep 10
2024 |
SKIL
|
Richard Walker
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 311 Added 1.21% |
-
|
Sep 10
2024 |
APP
|
Dawson Alyssa Harvey |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 12.77% |
$131,850
$87.9 p/Share
|
Sep 10
2024 |
PENN
|
David A Handler |
BUY
Open market or private purchase
|
Direct | 10,000 Added 3.3% |
$175,100
$17.51 p/Share
|
Sep 10
2024 |
INXB
|
Kristiina Md Vuori
Director |
BUY
Open market or private purchase
|
Direct | 179 Added 2.39% |
$2,685
$15.0 p/Share
|
Sep 10
2024 |
CPSS
|
Charles E Bradley Jr
CEO |
SELL
Open market or private sale
|
Direct | 70,000 Reduced 1.85% |
$689,500
$9.85 p/Share
|
Sep 10
2024 |
SYRS
|
Conley Chee
President & CEO |
BUY
Open market or private purchase
|
Direct | 50,000 Added 40.81% |
$75,500
$1.51 p/Share
|
Sep 10
2024 |
SYRS
|
Jason Haas
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 35,363 Added 37.12% |
$54,812
$1.55 p/Share
|
Sep 10
2024 |
AZYO
|
Matthew Ferguson
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 10,527 Reduced 3.28% |
$43,581
$4.14 p/Share
|
Sep 10
2024 |
AZYO
|
Matthew Ferguson
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 29,500 Added 8.41% |
-
|
Sep 10
2024 |
AZYO
|
C Randal Mills
PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,664 Reduced 3.67% |
$40,008
$4.14 p/Share
|
Sep 10
2024 |
AZYO
|
C Randal Mills
PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 27,084 Added 9.32% |
-
|
Sep 10
2024 |
AZYO
|
Michelle Le Roux Williams
CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 3,951 Reduced 6.19% |
$16,357
$4.14 p/Share
|
Sep 10
2024 |
AZYO
|
Michelle Le Roux Williams
CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 12,500 Added 16.38% |
-
|
Sep 10
2024 |
AMEH
|
Linda Marsh
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 3,522 Reduced 4.36% |
$168,809
$47.93 p/Share
|
Sep 10
2024 |
AMEH
|
Linda Marsh
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 11,000 Added 11.99% |
$168,850
$15.35 p/Share
|
Sep 10
2024 |
CHRD
|
Douglas E Brooks
Director |
SELL
Open market or private sale
|
Direct | 2 Reduced 0.01% |
$286
$143.18 p/Share
|
Sep 10
2024 |
CHRD
|
Douglas E Brooks
Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 3 Added 0.01% |
$226
$75.57 p/Share
|
Sep 10
2024 |
MAS
|
Kenneth G. Cole
VP, General Counsel and Sec. |
SELL
Open market or private sale
|
Direct | 37,814 Reduced 50.56% |
$2,961,214
$78.31 p/Share
|
Sep 10
2024 |
MAS
|
Kenneth G. Cole
VP, General Counsel and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct | 18,750 Added 20.04% |
$478,312
$25.51 p/Share
|
Sep 10
2024 |
HONE
|
David E. Tryder
SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 46.17% |
$162,240
$12.48 p/Share
|
Sep 10
2024 |